Sientra Inc (SIEN):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Sientra Inc (SIEN) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C6432)・商品コード:DATA904C6432
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:57
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company’s products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices such as vaginal stents, reconstructive products and specialty products. It offers services such as simplified account setup, monthly credit card style, billing system, easy orders and returns, one-of-a-kind capcon care program, and free shipping and returns. The company develops aesthetics medicine and plastic surgery implants for cosmetic and reconstructive markets. It markets its products across the US. Sientra is headquartered in Santa Barbara, California, the US.

Sientra Inc (SIEN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Sientra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Sientra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Sientra Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 11
Venture Financing 12
Miramar Labs Raises Additional USD2.3 Million in Venture Financing 12
Miramar Labs Raises USD2 Million in Venture Financing 13
Miramar Labs Raises USD1.2 Million in Financing Round 14
Miramar Labs Raises USD16 Million in Extended Series D Venture Financing 15
Miramar Labs Raises US$10 Million In Series D Financing 16
Miramar Labs Raises US$10 Million In Venture Financing 18
Miramar Labs US$5 Million In Venture Financing 19
Sientra Raises US$65 Million In Series C Financing 20
Private Equity 22
Miramar Labs Raises USD9 Million in Financing 22
Merger 24
Miramar Labs And Miramar Technologies Complete Reverse Merger Transaction 24
Equity Offering 25
Sientra Raises USD115 Million in Public Offering of Shares 25
Sientra to Raise up to USD50 Million in Public Offering of Shares 27
Sientra Raises USD66 Million in Public Offering of Shares 28
Sientra Raises USD75 Million in IPO 30
Asset Transactions 31
Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 31
Acquisition 32
Sientra Acquires Miramar Labs 32
Sientra Inc – Key Competitors 34
Sientra Inc – Key Employees 35
Sientra Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Financial Announcements 37
Aug 07, 2018: Sientra reports second quarter 2018 financial results 37
May 09, 2018: Sientra Reports First Quarter 2018 Financial Results 39
Mar 13, 2018: Sientra Reports Fourth Quarter and Full Year 2017 Financial Results 40
Jan 08, 2018: Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue 42
Nov 07, 2017: Sientra Reports Third Quarter 2017 Financial Results 44
Aug 09, 2017: Sientra Reports Second Quarter 2017 Financial Results 45
May 09, 2017: Sientra Reports First Quarter 2017 Financial Results 46
Mar 14, 2017: Sientra Reports Fourth Quarter and Full Year 2016 Financial Results 47
Corporate Communications 49
Oct 06, 2017: Sientra Supports Reconstructive Breast Patients with Launch of Full Circle Grant Program and Revolutionary Portfolio of Tissue Expanders 49
Mar 01, 2017: Sientra Appoints Vidur Sahney as Vice President, Operations and Supply Chain 50
Feb 07, 2017: Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors 51
Product News 52
Apr 25, 2018: Sientra to Showcase OPUS Breast Products and miraDry fresh Procedure at American Society of Aesthetic Plastic Surgeons Meeting 52
Apr 18, 2018: Sientra Receives FDA Approval of PMA Supplement 53
Sep 28, 2017: Comprehensive Analysis of Long-Term Safety Studies Reaffirms Smooth and Textured Breast Implants as Safe & Important Option for Patients Undergoing Aesthetic or Reconstructive Breast Surgery 54
Other Significant Developments 55
Aug 15, 2018: Sientra FULL CIRCLE grant applications open to U.S. Breast Cancer Organizations 55
Sep 14, 2017: Industry Leaders Allergan and Sientra Invest in The American Society for Aesthetic Plastic Surgery for Breast Implant Research 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Sientra Inc, Medical Equipment, Key Facts, 2017 2
Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Sientra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Sientra Inc, Deals By Market, 2012 to YTD 2018 9
Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 11
Miramar Labs Raises Additional USD2.3 Million in Venture Financing 12
Miramar Labs Raises USD2 Million in Venture Financing 13
Miramar Labs Raises USD1.2 Million in Financing Round 14
Miramar Labs Raises USD16 Million in Extended Series D Venture Financing 15
Miramar Labs Raises US$10 Million In Series D Financing 16
Miramar Labs Raises US$10 Million In Venture Financing 18
Miramar Labs US$5 Million In Venture Financing 19
Sientra Raises US$65 Million In Series C Financing 20
Miramar Labs Raises USD9 Million in Financing 22
Miramar Labs And Miramar Technologies Complete Reverse Merger Transaction 24
Sientra Raises USD115 Million in Public Offering of Shares 25
Sientra to Raise up to USD50 Million in Public Offering of Shares 27
Sientra Raises USD66 Million in Public Offering of Shares 28
Sientra Raises USD75 Million in IPO 30
Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 31
Sientra Acquires Miramar Labs 32
Sientra Inc, Key Competitors 34
Sientra Inc, Key Employees 35
Sientra Inc, Subsidiaries 36

List of Figures
Sientra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Sientra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Sientra Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★調査レポート[Sientra Inc (SIEN):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C6432)販売に関する免責事項を必ずご確認ください。
★調査レポート[Sientra Inc (SIEN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆